Article Per Year (5 Year)
p-Index From 2020 - 2025
1.633
P-Index
This Author published in this journals
All Journal Jurnal Ilmu Kefarmasian Indonesia Jurnal Pengabdian Masyarakat Indonesia Pharmaceutical And Biomedical Sciences Journal (PBSJ) Pharmaceutical Sciences and Research (PSR) Sciences of Pharmacy
Reise Manninda
Fakultas Farmasi, Universitas Pancasila, Indonesia
Agriculture, Biological Sciences & Forestry Humanities Biochemistry, Genetics & Molecular Biology Chemical Engineering, Chemistry & Bioengineering Education Engineering Health Professions Medicine & Pharmacology Public Health Social Sciences

Published : 9 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 9 Documents
Search

 1 
Analisis Dampak Program Pengelolaan Penyakit Kronis (Prolanis) Dalam Meningkatkan Outcome Klinis Pasien Diabetes Melitus Tipe 2 Di Puskesmas Jakarta, Indonesia Reise Manninda; Yusi Anggriani; Astrid Kartika Sari
JURNAL ILMU KEFARMASIAN INDONESIA Vol 19 No 2 (2021): JIFI
Publisher : Fakultas Farmasi Universitas Pancasila

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.35814/jifi.v19i2.1107

Abstract

Prolanis is a Chronic Disease Management Program under the Indonesian National Health Insurance for promoting and preventing chronic disease. Main activities of Prolanis program are disease control and counseling, scheduled education, scheduled exercise, participant’s remainder, and home visit. The aim of this study was to evaluate the impact of prolanis on the clinical outcome in type 2 Diabetes Mellitus (DM) patients. An observational retrospective study was evaluated for 12 months. Data was collected from medical record. 426 patients from five primary health care center in Jakarta was selected by simple random sampling and divided into prolanis and non-prolanis groups. The indicators were the difference of clinical outcome between prolanis and non-prolanis patients was analyzed using Mann-Whitney test; the correlation of adherence with clinical outcome was analyzed using Chi-Square test.The results showed that prolanis patients had a significant improvement in Fasting Blood Glucose (FBG) compared with non-prolanis patients (P<0.05). The adherence of prolanis patients showed a significant improvement on FBG (124 patients-58.2%). Patients with nonadherence had lower improvement on FBG, the improvement was observed only at 16 patients (7.5%) and 60 patients (28.17%) was poor FBG. Prolanis is an effective program to improve the clinical outcome of DM patients.
Analisis Efektivitas Biaya Pengobatan Kombinasi Zidovudin, Lamivudin, Nevirapin dan Kombinasi Tenofovir, Lamivudin, Efavirenz Pada Pasien HIV/AIDS di RSUD Kota Bekasi Yusi Anggriani; Fredrick D. Purba; Reise Manninda; Tarsinah Tarsinah
JURNAL ILMU KEFARMASIAN INDONESIA Vol 18 No 2 (2020): JIFI
Publisher : Fakultas Farmasi Universitas Pancasila

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.35814/jifi.v18i2.905

Abstract

HIV/AIDS has become a global issue in many countries. The implementation of ARV / HAARTprograms is always changing, due to clinical reasons, population factors, and aff ordability. Pharmacoeconomic studies can be one of the considerations in the policy process for procurement and selection of therapy regimens. The aims of this study were to determine the eff ectiveness of treatment based on CD4 increase and cost eff ectiveness analysis of HAART A and HAART B treatment regimens. This study used a cross sectional observation method. Retrospective data collection and non-experimental observation where conducted followes by a quantitative descriptive analysis according to the patient's perspective to obtain costeffectiveness data. Data were statistically analyzed to obtain the cost-eff ectiveness of treatment. The results showed that the cost-eff ectiveness analysis (CEA) of two regimens found that HAART A was more dominant than HAART B with a signifi cant diff erence p<0.05. While ACER regimen HAART A (16,227) was greater than the value ACER therapy B (28,330.7).
Faktor Resiko Penyebab Multidrug Resistant Tuberkulosis: Sistematik Review Mita Restinia; Sondang Khairani; Reise Manninda
Pharmaceutical and Biomedical Sciences Journal (PBSJ) Vol 3, No 1 (2021)
Publisher : UIN Syarif Hidayatullah Jakarta

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (379.775 KB) | DOI: 10.15408/pbsj.v3i1.20049

Abstract

Indonesia merupakan negara kedua dengan jumlah kasus tuberkulosis terbanyak di dunia. Pengobatan Tuberkulosis di Indonesia semakin sulit dengan munculnya Multidrug Resistant Tuberculosis (MDR-TB). Penelitian dilakukan untuk mengetahui faktor resiko yang menyebabkan terjadinya MDRT-TB di Indonesia. Sistematik review dilakukan terhadap artikel dengan studi case control. MDR-TB sebagai kelompok kasus dan Non MDR-TB sebagai kelompok kontrol. Artikel yang dipilih adalah artikel yang dipublikasikan pada tahun 2015-2020. Artikel dicari  melalui database google schoolar dan dianalisa menggunakan Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA). Terdapat 9 original artikel yang memenuhi kriteria inklusi untuk dianalisa. Faktor resiko terjadinya MDR-TB dibagi menjadi tiga kelompok yaitu karakteristik responden, Riwayat TB dan pengobatan, dan komorbiditas. Karakteristik responden yang signifikan mempengaruhi terjadinya MDR TB adalah dukungan keluarga, pengetahuan, usia, dan akses ke fasilitas kesehatan. Tidak patuh minum obat, adanya riwayat pengobatan TB, tidak aktif pengawas minum obat, efek samping obat dan adanya komorbiditas juga merupakan faktor resiko terjadinya MDR-TB.  Hasil yang diperoleh dapat disimpulkan bahwa identifikasi faktor resiko terjadinya MDR TB perlu dilakukan dengan baik. Selain itu, Pasien TB yang memiliki faktor resiko perlu diberikan edukasi yang lebih komprehensif dan pengawasan minum obat secara lebih ketat  untuk mencegah terjadinya MDR TB.
Perbandingan Penggunaan Efavirenz dan Nevirapine Terhadap Kolesterol LDL Pasien HIV/AIDS Anggriani, Yusi; Yunihastuti, Evy; Trisna, Yulia; Rosanti, Ade; Manninda, Reise; Annisa, Rifka
Pharmaceutical Sciences and Research Vol. 6, No. 2
Publisher : UI Scholars Hub

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Lipid metabolism disorder is one of common condition among HIV (Human Immunodeficiency Virus)/AIDS (Acquired Immune Deficiency Syndrome) patients who used first line antiretroviral efavirenz and nevirapine. This study was conducted to compare LDL (Low Density Lipoprotein) cholesterol between two group HIV/AIDS patients with efavirenz and nevirapine. The prospective study was performed in 2 months. HIV/AIDS patients who used first line antiretroviral at least for 6 months, aged ≥18 years old, not pregnant, without Mycobacterium ovium complex opportunistic infection and antihyperlipidemic, corticosteroid, retinoid in last 3 months were included. The 70 patients who enrolled in this study were divided into two groups. The independent T test was carried out to analyze the different of LDL cholesterol between two group. The group of patients using efavirenz showed 142.31 ±41,461 mg/dL and the group of nevirapine 126.83 ±40,55 mg/dL LDL cholesterol. This study showed that patient with efavirenze had higher LDL than nevirapine, but not statistically different.
Edukasi Penggunaan Antibiotik secara Tepat sebagai Upaya Melindungi Masyarakat dari Bahaya Resistensi Esti Mulatsari; Reise Manninda; Sondang Khairani; Shirly Kumala; Fauzia Noprima Okta
Jurnal Pengabdian Masyarakat Indonesia Vol 3 No 3 (2023): JPMI - Juni 2023
Publisher : CV Infinite Corporation

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.52436/1.jpmi.1081

Abstract

Penggunaan obat yang tidak rasional sudah menjadi masalah dunia, berkisar 50% obat-obatan diresepkan, didistribusikan, dijual dan digunakan pasien secara tidak tepat. Penggunaan obat yang tidak rasional menjadi fokus perhatian adalah penggunaan antibiotik yang tidak sesuai baik dari jenis obat, dosis, lama pemberian dan penggunaan yang berlebihan pada penyakit non infeksi bakteri. Kondisi ini memicu terjadinya resistensi terhadap antibiotik. Masyarakat banyak menggunakan antibiotik untuk mengatasi penyakit non infeksi seperti batuk, flu, demam tanpa resep dokter dan dijual bebas pada beberapa fasilitas kesehatan yang tidak paham tentang regulasi di Indonesia. Tujuan kegiatan ini memberikan informasi kepada masyarakat tentang bahaya penggunaan antibotik yang tidak tepat. Kegiatan pengabdian kepada masyarakat ini dilakukan dalam bentuk penyuluhan dan pemutaran video DAGUSIBU penggunaan antibiotik. Pengukuran keberhasilan kegiatan dilakukan dengan memberikan pretest dan postets kepada masyarakat peserta kegiatan. Perhitungan persentasi total masyarakat yang dapat menjawab soal dengan tepat. Dari hasil pengolahan data, diketahui bahwa terjadi peningkatan pemahaman dan pengetahuan masyarakat terkait resistensi antibiotik setelah diberikan penyuluhan.
Polypharmacy and the occurrence of potential drug interactions in geriatric Covid-19 patients in Karawang General Regional Hospital, Indonesia Khairani, Sondang; Manninda, Reise; Sarah, Mutia
JURNAL ILMU KEFARMASIAN INDONESIA Vol 22 No 2 (2024): JIFI
Publisher : Faculty of Pharmacy, Universitas Pancasila

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.35814/jifi.v22i2.1662

Abstract

The management of COVID-19 treatment continues to evolve by involving various types of drugs both symptomatic and supportive therapy. COVID-19 infection with comorbid conditions in geriatric patients can have an effect on increasing drug use and the potential for drug interactions. The purpose of the study was to determine whether there is a relationship between the level of polypharmacy and the incidence of potential drug interactions at Karawang Regency Hospital for the period January to December 2021. The research method used was a cross-sectional study design. The data collected was hospital secondary data with retrospective data type and statistical analysis using Spearman Rho. The research material used was medical record data from 182 samples using the total sampling method. Based on the results of the study, it was found that as many as 108 (59.3%) patients received treatment with a total of 5-9 types of drugs. Potential drug interactions were experienced by 148 (81.3%) patients with a total of 764 events. There is a relationship between the level of polypharmacy and the potential incidence of drug interactions (r: 0.537, p: <0.001).
Cost effectiveness analysis of ceftriaxone with cefoperazon in thypoid patients at X Mataram Hospital Khairani, Sondang; Manninda, Reise; Widodo, Akhmad Fajri; Raharjo, Lalu Joko
JURNAL ILMU KEFARMASIAN INDONESIA Vol 22 No 1 (2024): JIFI
Publisher : Faculty of Pharmacy, Universitas Pancasila

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.35814/jifi.v22i1.1585

Abstract

Typhoid is the third most common cause of hospitalisation in Indonesia, affecting 100,000 people every year. Typhoid fever, with an average case fatality rate of 2.45% at X Mataram Hospital, was among the top 10 most common inpatient illnesses in 2019 and 2020. Antibiotics are effective in reducing typhoid infection, lowering body temperature, shortening the length of hospitalisation, and reducing mortality. The aim study to determine the cost-effectiveness of using ceftriaxone and cefoperazone antibiotics for typhoid patients at X Mataram Hospital. Method a compares two groups of antibiotics and evaluates direct costs and clinical outcomes clinic (length of stay and time free of fever). This research is using ACER's cost-effectiveness analysis. The study included 63 samples with an average direct cost of Rp 3,645,106 for cefoperazon and Rp 3,168,106 for ceftriaxone. According to the ACER analysis results, hospitalisation with ceftriaxone is more cost-effective a lower cost of Rp 704,023 and based on fever-free time, cefoperazone is more cost-effective at Rp. 1,024,094. No correlation between antibiotic effectiveness and fever-free time, no correlation between antibiotic effectiveness and length of hospitalisation (p-value >0.05).
Evaluation of Medication Errors in Transcribing and Dispensing Processes of Outpatient E-Prescriptions at Persahabatan General Hospital Khairani, Sondang; Nurhayati, Fitri; Kurnia, Mala; Manninda, Reise; Ariani, Lusiana
Sciences of Pharmacy Volume 4 Issue 2
Publisher : ETFLIN Publishing House

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.58920/sciphar0402316

Abstract

Persahabatan General Hospital provides a variety of healthcare services, including outpatient care. Medication errors are errors in the prescribing, dispensing, and administration process that can be considered risk factors for patients. This study aims to evaluate medication errors in the transcription and dispensing phases of outpatient e-prescriptions at Persahabatan General Hospital during the period January - February 2024. This research is a descriptive observational study with a cross-sectional design. Data were collected through prospective observation and analyzed descriptively to determine the percentage of medication errors. Of the 363 e-prescriptions observed, the results showed no errors in the transcribing phase. However, in the dispensing phase, there were 50 (6.07%) incidents of incorrect preparing quantity of medicine, 8 (0.97%) incidents of incorrect medicine medical equipment, and 7 (0.85%) incidents of incorrect dosage. These findings suggest that although the implementation of e-prescribing is effective in reducing errors at the transcription phase, special attention must be paid to the dispensing phase to reduce the number of errors. There is a correlation between polypharmacy and medication errors in the dispensing phase, p-value <0.001. All of these errors are resolved before the medication is administered to the patient.
Evaluation of the rationality of drugs use inpatient patients with type 2 diabetes mellitus of 2023 at Hospital Y Depok Khairani, Sondang; Manninda, Reise; Wijayanti, Bitya Aulia
JURNAL ILMU KEFARMASIAN INDONESIA Vol 23 No 1 (2025): JIFI
Publisher : Faculty of Pharmacy, Universitas Pancasila

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.35814/jifi.v23i1.1694

Abstract

Diabetes mellitus is a chronic disease caused by failure to control blood glucose levels. Type 2 Diabetes Mellitus (T2DM) is a condition of hyperglycemia caused by the failure of insulin to maintain balanced blood sugar levels. If T2DM is not treated it will cause complications. One way to control T2DM is the rational use of antidiabetic drugs. This study aims to look at the demographic data of inpatients with T2DM, patterns of drug use, rationality for drug use, and the relationship between the rationality of drug use and therapeutic outcomes in inpatients with T2DM at Hospital Y Depok for the period 2023. The outcome evaluated is a random blood sugar test. The research method was carried out descriptively and inferentially with a cross-sectional design. There were 122 samples that met the inclusion criteria, women predominantly suffered from type 2 diabetes mellitus (50.89%). The most common age range was 46-65 years (64.56%). As many as 84.31% of patients used the JKN payment method. The most widely used class of type 2 diabetes mellitus medication is insulin. In evaluating the rationality of using type 2 diabetes mellitus drugs, the rationality results were 99.49% correct drug, 100% correct dose, and 98.73% correct administration. The results of statistical tests show that there is a correlation between the rationality of drug use and clinical outcomes p-value 0.001.
Co-Authors Ade Rosanti Anggriani, Yusi Annisa, Rifka Ariani, Lusiana Astrid Kartika Sari Evy Yunihastuti Fauzia Noprima Okta Fitri Nurhayati Fredrick D. Purba Kurnia, Mala Mita Restinia Mulatsari, Esti Raharjo, Lalu Joko Rifka Annisa Rosanti, Ade S.Farm., M.Farm., Apt, Sondang Khairani Sarah, Mutia Shirly Kumala Tarsinah Tarsinah Widodo, Akhmad Fajri Wijayanti, Bitya Aulia Yulia Trisna Yulia Trisna, Yulia Yusi Anggriani Yusi Anggriani